Russia’s Enteromix mRNA vaccine achieved 100% efficacy in preclinical trials, showing remarkable tumor-fighting power and safety. Reported by ANI, the vaccine significantly reduced tumor growth by 60–80% and boosted survival rates. Veronika Skvortsova, FMBA head, shared these findings at the Eastern Economic Forum, noting the vaccine’s readiness for approval.
Enteromix initially targets colorectal cancer, a major global killer, with versions for glioblastoma and melanoma in advanced development. Unlike traditional vaccines for diseases like measles, cancer vaccines like Enteromix train the immune system to attack cancer cells directly.
This therapeutic approach strengthens the body’s natural defenses, offering hope for more effective cancer treatments. Announced at the 10th Eastern Economic Forum in Vladivostok (September 3–6, 2025), Enteromix captivated over 8,400 delegates from 75 countries.
The forum, themed “The Far East: Cooperation for Peace and Prosperity,” highlighted this potential game-changer in cancer care.
If approved, Enteromix could redefine cancer treatment worldwide, marking a historic milestone.
Cancer happens when cells in the body grow uncontrollably, forming tumors or spreading to other areas. Normally, cells grow, divide, and die in an orderly way, but changes in DNA, called mutations, can disrupt this process. These mutations may come from genetics, lifestyle factors like smoking, or environmental exposures such as UV rays or chemicals. Infections like HPV can also increase cancer risk.
When mutated cells ignore signals to stop growing, they can form harmful tumors. Sometimes, these cells break away and spread, a process called metastasis. According to the American Cancer Society, early detection and healthy habits, like avoiding tobacco and eating well, can lower cancer risk. Understanding why cancer starts helps scientists develop treatments like Russia’s Enteromix vaccine to fight it effectively.
Stay informed and proactive to protect your health!
On September 10, 2025, Oracle Financial Services Software (OFSS) surged over 7% on Indian exchanges, driven primarily by its parent company Oracle Cor
The Flipkart Big Billion Days Sale 2025, starting September 23, is India’s ultimate festive shopping event, offering massive discounts on smartphones,
Life insurance providers are well-prepared to navigate the GST exemption on premiums, effective September 22, 2025. Despite the loss of input tax cred
Adani Power and Druk Green sign ₹6,000 crore deal for 570 MW Wangchhu hydro project in Bhutan, starting 2026.